Regulation of the MIE Locus During HCMV Latency and Reactivation

Overview

Journal Pathogens

Date 2020 Oct 29

PMID 33113934

Citations 29

Authors

Abigail L Dooley

Christine M OConnor

Affiliations

Soon will be listed here.

Abstract

Human cytomegalovirus (HCMV) is a ubiquitous herpesviral pathogen that results in life-long infection. HCMV maintains a latent or quiescent infection in hematopoietic cells, which is broadly defined by transcriptional silencing and the absence of de novo virion production. However, upon cell differentiation coupled with immune dysfunction, the virus can reactivate, which leads to lytic replication in a variety of cell and tissue types. One of the mechanisms controlling the balance between latency and reactivation/lytic replication is the regulation of the major immediate-early (MIE) locus. This enhancer/promoter region is complex, and it is regulated by chromatinization and associated factors, as well as a variety of transcription factors. Herein, we discuss these factors and how they influence the MIE locus, which ultimately impacts the phase of HCMV infection.

Citing Articles

Inhibition of MAPK signaling suppresses cytomegalovirus reactivation in CD34 Kasumi-3 cells.

Baruah V, Krishna B, Kelly M, Qi X, OConnor C bioRxiv. 2025; .

PMID: 39990446 PMC: 11844548. DOI: 10.1101/2025.02.13.638080.

The functions of herpesvirus shuttling proteins in the virus lifecycle.

Cao H, Wang M, Cheng A, Tian B, Yang Q, Ou X Front Microbiol. 2025; 16:1515241.

PMID: 39973925 PMC: 11837949. DOI: 10.3389/fmicb.2025.1515241.

Impact of Combined Antiretroviral Treatment (cART) on Latent Cytomegalovirus Infection.

Temereanca A, Ene L, Tardei G, Grancea C, Achim C, Ruta S Viruses. 2025; 17(1).

PMID: 39861865 PMC: 11768569. DOI: 10.3390/v17010076.

Enhancers and genome conformation provide complex transcriptional control of a herpesviral gene.

Morgens D, Gulyas L, Mao X, Rivera-Madera A, Souza A, Glaunsinger B Mol Syst Biol. 2024; 21(1):30-58.

PMID: 39562742 PMC: 11696879. DOI: 10.1038/s44320-024-00075-0.

Virus-Specific Nanobody-Chimeras Degrade the Human Cytomegalovirus US28 Protein in CD34+ Cells.

Poole E, Schmitt J, Graham S, Kelly B, Sinclair J Pathogens. 2024; 13(10).

PMID: 39452693 PMC: 11510245. DOI: 10.3390/pathogens13100821.

References

Nitzsche A, Steinhausser C, Mucke K, Paulus C, Nevels M . Histone H3 lysine 4 methylation marks postreplicative human cytomegalovirus chromatin. J Virol. 2012; 86(18):9817-27. PMC: 3446588. DOI: 10.1128/JVI.00581-12. View

Boeckh M, Leisenring W, Riddell S, Bowden R, Huang M, Myerson D . Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood. 2002; 101(2):407-14. DOI: 10.1182/blood-2002-03-0993. View

Zhang Y, Chen Y, Liu Z, Lai R . ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination. BMC Cancer. 2018; 18(1):613. PMC: 5984314. DOI: 10.1186/s12885-018-4539-7. View

Woodhall D, Groves I, Reeves M, Wilkinson G, Sinclair J . Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J Biol Chem. 2006; 281(49):37652-60. DOI: 10.1074/jbc.M604273200. View

Stewart M . Optimal management of cytomegalovirus retinitis in patients with AIDS. Clin Ophthalmol. 2010; 4:285-99. PMC: 2861935. DOI: 10.2147/opth.s6700. View

Zhang X, Inamdar N, Supakar P, Wu K, Ehrlich K, Ehrlich M . Three MDBP sites in the immediate-early enhancer-promoter region of human cytomegalovirus. Virology. 1991; 182(2):865-9. DOI: 10.1016/0042-6822(91)90631-k. View

Hagemeier C, Walker S, Sissons P, Sinclair J . The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements. J Gen Virol. 1992; 73 ( Pt 9):2385-93. DOI: 10.1099/0022-1317-73-9-2385. View

Kim J, Collins-McMillen D, Buehler J, Goodrum F, Yurochko A . Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34 Human Progenitor Cells. J Virol. 2016; 91(5). PMC: 5309964. DOI: 10.1128/JVI.01206-16. View

Huang T, Oka T, Asai T, Okada T, Merrills B, Gertson P . Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. Nucleic Acids Res. 1996; 24(9):1695-701. PMC: 145859. DOI: 10.1093/nar/24.9.1695. View

10.

Nguyen Q, Estey E, Raad I, Rolston K, Kantarjian H, Jacobson K . Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis. 2001; 32(4):539-45. DOI: 10.1086/318721. View

11.

Mocarski E, Wiedeman J . Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood. 1998; 93(1):394-8. View

12.

Hargett D, Shenk T . Experimental human cytomegalovirus latency in CD14+ monocytes. Proc Natl Acad Sci U S A. 2010; 107(46):20039-44. PMC: 2993366. DOI: 10.1073/pnas.1014509107. View

13.

Lee S, Albright E, Lee J, Jacobs D, Kalejta R . Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein. Sci Adv. 2015; 1(10):e1501164. PMC: 4681346. DOI: 10.1126/sciadv.1501164. View

14.

Rauwel B, Jang S, Cassano M, Kapopoulou A, Barde I, Trono D . Release of human cytomegalovirus from latency by a KAP1/TRIM28 phosphorylation switch. Elife. 2015; 4. PMC: 4384640. DOI: 10.7554/eLife.06068. View

15.

Teira P, Battiwalla M, Ramanathan M, Barrett A, Ahn K, Chen M . Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016; 127(20):2427-38. PMC: 4874224. DOI: 10.1182/blood-2015-11-679639. View

16.

Hammond S, Martin S, Roberts K, Gabardi S, Fuhlbrigge A, Camp P . Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis. Transpl Infect Dis. 2012; 15(2):163-70. DOI: 10.1111/tid.12036. View

17.

Kong Q, Wu M, Huan Y, Zhang L, Liu H, Bou G . Transgene expression is associated with copy number and cytomegalovirus promoter methylation in transgenic pigs. PLoS One. 2009; 4(8):e6679. PMC: 2723931. DOI: 10.1371/journal.pone.0006679. View

18.

Scott E, Simon M, Anastasi J, Singh H . Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994; 265(5178):1573-7. DOI: 10.1126/science.8079170. View

19.

Chou S, Satterwhite L, Ercolani R . New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by Exposure to Letermovir and Ganciclovir. Antimicrob Agents Chemother. 2018; 62(9). PMC: 6125535. DOI: 10.1128/AAC.00922-18. View

20.

Nitzsche A, Paulus C, Nevels M . Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells. J Virol. 2008; 82(22):11167-80. PMC: 2573275. DOI: 10.1128/JVI.01218-08. View